CoChat

Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: Post‐hoc analyses of four clinical trials

Open access
Tonneijck, Lennart, Muskiet, Marcel H. A., Smits, Mark M., Bjornstad, Petter, Kramer, Mark H. H., Diamant, Michaela, Hoorn, Ewout J., Joles, Jaap A., van Raalte, Daniël H. · 2018 · Diabetes, Obesity and Metabolism
Cited by 47

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Aims: To determine the effects of glucagon‐like peptide (GLP)‐1 receptor agonists (RA) on uric acid (UA) levels and kidney UA clearance. Material and methods: This study involved post‐hoc analyses of 4 controlled clinical trials, which assessed actions of GLP‐1RA administration on kidney physiology. The immediate effects of GLP‐1RA exenatide infusion vs placebo were determined in 9 healthy overweight men (Study‐A) and in 52 overweight T2DM patients (Study‐B). The effects of 12 weeks of long‐acting GLP‐1RA liraglutide vs placebo in 36 overweight T2DM patients (Study‐C) and of 8 weeks of short‐acting GLP‐1RA lixisenatide vs once‐daily titrated insulin glulisine in 35 overweight T2DM patients (Study‐D) were also examined. Plasma UA, fractional (inulin‐corrected) and absolute urinary excretion of UA (UE UA ) and sodium (UE Na ), and urine pH were determined. Results: Median baseline plasma UA level was 5.39 to 6.33 mg/dL across all studies (17%‐22% of subjects were hyperuricaemic). In Study‐A, exenatide infusion slightly increased plasma UA (+0.07 ± 0.02 mg/dL, P = .04), and raised absolute‐UE UA (+1.58 ± 0.65 mg/min/1.73 m 2 , P = .02), but did not affect fractional UE UA compared to placebo. Fractional UE UA and absolute UE UA correlated with increases in urine pH (r:0.86, P = .003 and r:0.92, P < .001, respectively). Fractional UE UA correlated with increased fractional UE Na (r:0.76, P = .02). In Study‐B, exenatide infusion did not affect plasma UA, but increased fractional UE UA (+0.76 ± 0.38%, P = .049) and absolute UE UA (+0.75 ± 0.27 mg/min/1.73 m 2 , P = .007), compared to placebo. In regression analyses, both parameters were explained by changes in urine pH and, in part, by changes in UE Na . In Study‐C, liraglutide treatment did not affect plasma UA, UE UA, UE Na or urine pH, compared to placebo. In Study‐D, lixisenatide treatment increased UE Na and urine pH from baseline, but did not affect plasma UA or UE UA . Conclusion: Immediate exenatide infusion increases UE UA in overweight healthy men and in T2DM patients, probably by inhibiting Na + /H + ‐exchanger type‐3 in the renal proximal tubule. Prolonged treatment with a long‐acting or short‐acting GLP‐1RA does not affect plasma UA or UE UA in T2DM patients with normal plasma UA levels and at relatively low cardiovascular risk. Our results suggest that the cardio‐renal benefits of GLP‐1RA are not mediated through changes in UA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.13223

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 47

Metadata

Authors
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Bjornstad, P., Kramer, M. H. H., Diamant, M., Hoorn, E. J., Joles, J. A., & van Raalte, D. H.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2018-02-20
Volume
20
Issue
5
Pages
1235-1245
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2793719460
Cited by
47
References
19
FWCI
3.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: Post‐hoc analyses of four clinical trials. https://app.cochat.ai/papers/10.1111/dom.13223
The paper
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Bjornstad, P., Kramer, M. H. H., Diamant, M., Hoorn, E. J., Joles, J. A., & van Raalte, D. H. (2018). Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: Post‐hoc analyses of four clinical trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.13223

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.